478 related articles for article (PubMed ID: 9129544)
41. [Three Dimensional Volumetric Analysis of Solid Pulmonary Nodules on Chest CT:
Cancer Risk Assessment].
Li M; Han R; Song W; Wang X; Guo F; Su D; Yu T; Wang Y
Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):279-85. PubMed ID: 27215456
[TBL] [Abstract][Full Text] [Related]
42. Evaluation and management of solitary and multiple pulmonary nodules.
Viggiano RW; Swensen SJ; Rosenow EC
Clin Chest Med; 1992 Mar; 13(1):83-95. PubMed ID: 1582151
[TBL] [Abstract][Full Text] [Related]
43. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
Cronin P; Dwamena BA; Kelly AM; Carlos RC
Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.
Jeong SY; Lee KS; Shin KM; Bae YA; Kim BT; Choe BK; Kim TS; Chung MJ
Lung Cancer; 2008 Aug; 61(2):186-94. PubMed ID: 18280613
[TBL] [Abstract][Full Text] [Related]
45. Decreased levels of sex hormones in females with solitary pulmonary nodules were risk factors for malignancy.
Wendan W; Mengyu L; Qiufeng Z
J Cardiothorac Surg; 2024 Mar; 19(1):119. PubMed ID: 38475837
[TBL] [Abstract][Full Text] [Related]
46. Nomogram For The Prediction Of Malignancy In Small (8-20 mm) Indeterminate Solid Solitary Pulmonary Nodules In Chinese Populations.
Chen XB; Yan RY; Zhao K; Zhang DF; Li YJ; Wu L; Dong XX; Chen Y; Gao DP; Ding YY; Wang XC; Li ZH
Cancer Manag Res; 2019; 11():9439-9448. PubMed ID: 31807073
[TBL] [Abstract][Full Text] [Related]
47. Solitary pulmonary nodules: CT assessment.
Siegelman SS; Khouri NF; Leo FP; Fishman EK; Braverman RM; Zerhouni EA
Radiology; 1986 Aug; 160(2):307-12. PubMed ID: 3726105
[TBL] [Abstract][Full Text] [Related]
48. Malignancy risk stratification for solitary pulmonary nodule: A clinical practice guideline.
Chen B; Li Q; Hao Q; Tan J; Yan L; Zhu Y; Hu C; Qian G; Zhang G; Chen L; Zhou C; Zhang J; Sun J; Jiang L; Zhang L; Wang Q; Zhang X; Jin Y; He Y; Song Y; Sun X; Li W
J Evid Based Med; 2022 Jun; 15(2):142-151. PubMed ID: 35775869
[TBL] [Abstract][Full Text] [Related]
49. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
[TBL] [Abstract][Full Text] [Related]
50. Communication About the Probability of Cancer in Indeterminate Pulmonary Nodules.
Maiga AW; Deppen SA; Massion PP; Callaway-Lane C; Pinkerman R; Dittus RS; Lambright ES; Nesbitt JC; Grogan EL
JAMA Surg; 2018 Apr; 153(4):353-357. PubMed ID: 29261826
[TBL] [Abstract][Full Text] [Related]
51. Biomarkers to help guide management of patients with pulmonary nodules.
Patz EF; Campa MJ; Gottlin EB; Trotter PR; Herndon JE; Kafader D; Grant RP; Eisenberg M
Am J Respir Crit Care Med; 2013 Aug; 188(4):461-5. PubMed ID: 23306547
[TBL] [Abstract][Full Text] [Related]
52. Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT.
Zhang M; Kono M
Radiology; 1997 Nov; 205(2):471-8. PubMed ID: 9356631
[TBL] [Abstract][Full Text] [Related]
53. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI?
Satoh S; Kitazume Y; Ohdama S; Kimula Y; Taura S; Endo Y
AJR Am J Roentgenol; 2008 Aug; 191(2):464-70. PubMed ID: 18647918
[TBL] [Abstract][Full Text] [Related]
54. Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.
Marcus MW; Duffy SW; Devaraj A; Green BA; Oudkerk M; Baldwin D; Field J
Thorax; 2019 Aug; 74(8):761-767. PubMed ID: 31028232
[TBL] [Abstract][Full Text] [Related]
55. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
56. A mathematical model for predicting malignancy of solitary pulmonary nodules.
Li Y; Wang J
World J Surg; 2012 Apr; 36(4):830-5. PubMed ID: 22297626
[TBL] [Abstract][Full Text] [Related]
57. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
[TBL] [Abstract][Full Text] [Related]
58. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
Lohrmann C; Weber WA
Zentralbl Chir; 2014 Feb; 139(1):108-13. PubMed ID: 24585199
[TBL] [Abstract][Full Text] [Related]
59. The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial Cohort.
White CS; Dharaiya E; Campbell E; Boroczky L
Radiology; 2017 Apr; 283(1):264-272. PubMed ID: 27740906
[TBL] [Abstract][Full Text] [Related]
60. Solitary pulmonary nodules: determining the likelihood of malignancy with neural network analysis.
Gurney JW; Swensen SJ
Radiology; 1995 Sep; 196(3):823-9. PubMed ID: 7644650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
